Writing mainly for the business section, she has specialized in the pharmaceutical and biotechnology industries. Her stories, both national and international, highlight the intersection between science, business, and society, investigating, for example, the impact of drug pricing on the health care system, or the financial relationships between doctors and big pharmaceutical groups.